OpenPass keeps COVID-19 symptoms off-campus and out-of-office

Oura Ring
Oura Ring

Academic institutions are tasked with weighing the tradeoffs of reopening amid unpredictable infection rates and student-led lawsuits claiming virtual platforms offer discounted academic experiences that should be met with commensurate changes in tuition.  Litigation from faculty highlights insufficient precautions that prevent staff exposure to COVID-19.  News of vaccine optimism comes with loose timelines to FDA approval and delivery.  Elevated unemployment, and diagnoses of mental-health and anxiety disorders, bring government calls for tech companies to deliver solutions that better mitigate COVID-19.

Riskovery, a tech team based near the Pentagon with a mobile app originally designed to protect multinational organizations from incident risks ranging from kidnapping, ransom, and crime, among others — including infectious diseases — now offers a means of circumnavigating the issue.  Riskovery’s customized software platform now pairs with leading biometric wearables to meet the needs of organizations in the COVID-19 environment.  Riskovery’s partnership with leading wearable-tech companies prevents the spread and contraction of COVID-19 and sets a new standard for pre-arrival COVID-19 clearance.  

An added bonus for academic and health enthusiasts: the benefit of user well-being data, ranging from sleep quality — several wearables started as panaceas for better sleep — to cognitive performance.

OpenPass — Establishing effective COVID-19 precautions to safely reopen commerce and in-person education 

Riskovery recognized shortfalls in symptom-checking solutions adopted across the country, such as temperature monitors and gate-pass scanners — which enable COVID-19 positive and asymptomatic to show up in-person and potentially infect others on-site.  

Being able to detect the presence of COVID-19 prior to arrival has been the key imperative in automating wearable technology to effectively inform large organizations of risks and keep community members safe. .

OpenPass solution relies on built-in sensors to monitor body temperature, heart rate, and oxygen saturation in blood.  This enables your organization to monitor and predict COVID-19 symptoms with over 90% accuracy and get as close to “all clear” as science allows, short of having a test taken after every human interaction.  

Where is this being implemented?

 You may have noticed the NBA recently bought 2000 smart rings to mitigate COVID-19 in “the bubble” and monitor player health.  Katelyn Gleason, CEO and Founder of Eligible, the leading billing infrastructure company for healthcare in the U.S tweeted her COVID experience with an Oura ring:

Researchers at both UCSF and WVU Rockefeller Neuroscience Institute (RNI) successfully forecasted temperature and a “Health Index” with parallel technology to predict the onset of COVID-19 related symptoms and infection signs in real time.

About Riskovery

 Learn more about OpenPass: 

Riskovery offers the industry’s leading technology and risk-mitigation solutions to help you navigate personnel, crisis-response, and COVID-19 security.  Experts in predictive analytics and business continuity management – contact us to help your organization adopt a safe and effective operational model.  

OpenPass – Automated COVID-19 Symptom Checker 

Request an OpenPass demo here to cautiously mitigate infection risks, pursuant to state and federal regulations, for the well-being of your organization and community.


Like this article?

Share on Facebook
Share on Twitter
Share on Linkedin